AEGIR — Aegirbio AB Share Price
0.000.00%
Last trade - 00:00- SEK17.39m
- SEK28.29m
- SEK1.71m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.32 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 175.65 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -680.72% | ||
| Return on Equity | -200.67% | ||
| Operating Margin | -368945.45% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | n/a | 0.01 | 13.28 | 1.71 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
AegirBio AB is a Sweden-based medicine company focused therapeutic drug monitoring of biologic therapies in the autoimmune, oncology and neurology space. The Company offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. It aims to provide personalized treatment by tracking drugs levels in individuals. Aegirbio combines core technologies from LifeAssays and Abreos Biosciences. LifeAssays is a diagnostics company based in Sweden, which owns the Magnia Point of Care and Point of Need reader technology. Abreos Biosciences is a California-based biotech, which is a developer of the Veritope chemistry platform for detecting levels of biologic drugs in patient samples.
Directors
- Anders Ingvarsson NEC (64)
- Martin Linde CEO (50)
- Fredrik Haglund IND (46)
- Seppo Makinen IND (69)
- Bradley Messmer IND (47)
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- October 14th, 2019
- Public Since
- June 26th, 2020
- No. of Employees
- 1
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 25,876,872
- Address
- Scheelevagen 27, LUND, 22363
- Web
- https://aegirbio.com/
- Phone
- Auditors
- KPMG AB
Upcoming Events for AEGIR
Aegirbio AB Annual Shareholders Meeting
Similar to AEGIR
Acarix AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
Arjo AB (publ)
OMX Nordic Exchange Stockholm
FAQ
What is the Aegirbio AB share price?
As of Today at 19:00 UTC, shares in Aegirbio AB are trading at SEK0.67. This share price information is delayed by 15 minutes.
How has the Aegirbio AB share price performed this year?
Shares in Aegirbio AB last closed at SEK0.67 and the price had moved by -69.03% over the past 365 days. In terms of relative price strength the Aegirbio AB share price has underperformed the FTSE Global All Cap Index by -71.44% over the past year.
What are the analyst and broker recommendations for Aegirbio AB?
There is no consensus recommendation for this security.
What is the Aegirbio AB dividend yield?
Aegirbio AB does not currently pay a dividend.
Does Aegirbio AB pay a dividend?
Aegirbio AB does not currently pay a dividend.
When does Aegirbio AB next pay dividends?
Aegirbio AB does not currently pay a dividend.
How do I buy Aegirbio AB shares?
To buy shares in Aegirbio AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Aegirbio AB?
As of the previous close price of SEK0.67, shares in Aegirbio AB had a market capitalisation of SEK17.39m.
Where are Aegirbio AB shares listed?
Here are the trading details for Aegirbio AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: AEGIR
What kind of share is Aegirbio AB?
Based on an overall assessment of its quality, value and momentum Aegirbio AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Aegirbio AB share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Aegirbio AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aegirbio AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -41.66%.
As of the last closing price of SEK0.67, shares in Aegirbio AB were trading -34.29% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Aegirbio AB PE Ratio?
The Aegirbio AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.67.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Aegirbio AB?
Aegirbio AB's management team is headed by:
- Anders Ingvarsson - NEC
- Martin Linde - CEO
- Fredrik Haglund - IND
- Seppo Makinen - IND
- Bradley Messmer - IND